Citation Impact
Citing Papers
The Macrophage Colony-Stimulating Factor 1 Response Signature in Breast Carcinoma
2009
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
2019 Standout
Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54
2003 Standout
TOR Signaling in Growth and Metabolism
2006 Standout
EglN2 associates with the NRF 1‐ PGC 1α complex and controls mitochondrial function in breast cancer
2015 StandoutNobel
Mechanisms of Endocrine Resistance in Breast Cancer
2010
Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy
2005
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
Letrozole in the extended adjuvant setting: MA.17
2007
A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis
2011
Estradiol Hypersensitivity and Mitogen-Activated Protein Kinase Expression in Long-Term Estrogen Deprived Human Breast Cancer Cellsin Vivo1
2000
Mammographic Density and the Risk and Detection of Breast Cancer
2007 Standout
Carbon nanotubes for delivery of small molecule drugs
2013
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Role of aromatase in endometrial disease
2001
mTOR Signaling in Growth Control and Disease
2012 Standout
Estrogen receptors and human disease
2006 Standout
Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to Treatment
2005
Tumor-Associated Macrophages in Breast Cancer
2002
AKT/PKB Signaling: Navigating Downstream
2007 Standout
Endometriosis
2009 Standout
Cushing's syndrome
2015 Standout
MICoA, a Novel Metastasis-associated Protein 1 (MTA1) Interacting Protein Coactivator, Regulates Estrogen Receptor-α Transactivation Functions
2003
Targeting mammalian target of rapamycin (mTOR) for health and diseases
2006
Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer
2010
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target
1999
Pre-eclampsia
2005 Standout
Leukocytes in Mammary Development and Cancer
2010
Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease
2010 Standout
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
2009 StandoutNature
Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer
2007
Monogenic Disorders of Puberty
2002
U1 snRNP regulates cancer cell migration and invasion in vitro
2020 Standout
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer
2003
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Treatment for the endocrine resistant breast cancer: Current options and future perspectives
2017
Aromatase as a Therapeutic Target in Endometriosis
2000
Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators
2005
Metformin and cancer therapy
2011
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Role of the Fas/Fas ligand system in female reproductive organs: survival and apoptosis
2002
Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancer
2003
Use of Reverse Phase Protein Microarrays and Reference Standard Development for Molecular Network Analysis of Metastatic Ovarian Carcinoma
2005
Endometriosis
2004 Standout
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Production and Actions of Estrogens
2002 Standout
Cushing's syndrome
2006 Standout
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
2006 Standout
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Ras, PI(3)K and mTOR signalling controls tumour cell growth
2006 StandoutNature
Dynamics and diversity in autophagy mechanisms: lessons from yeast
2009 StandoutNobel
Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal Women
2004 Standout
Drugging the undruggable RAS: Mission Possible?
2014
Termination of autophagy and reformation of lysosomes regulated by mTOR
2010 StandoutNature
Quantitative Assessment of Mammographic Breast Density: Relationship with Breast Cancer Risk
2004
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
mTOR — beyond transplantation
2005
Preventing Relapse Beyond 5 Years: The MA.17 Extended Adjuvant Trial
2006
Endogenous Steroid Hormone Concentrations and Risk of Breast Cancer Among Premenopausal Women
2006 Standout
Preservation of Fertility in Patients with Cancer
2009 Standout
Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer
2005
Oestrogen exposure and breast cancer risk
2003
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
2006 Standout
PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding
2007
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
2012 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Aromatase Inhibitors in the Treatment of Breast Cancer
2005
Cross-Talk between Estrogen Receptor and Growth Factor Pathways as a Molecular Target for Overcoming Endocrine Resistance
2004
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Amphiregulin Is Coordinately Expressed with Heparin-Binding Epidermal Growth Factor-Like Growth Factor in the Interstitial Smooth Muscle of the Human Prostate1
1999
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
2013 Standout
Clinical and Molecular Features of the Carney Complex: Diagnostic Criteria and Recommendations for Patient Evaluation
2001
Testosterone inhibits early atherogenesis by conversion to estradiol: Critical role of aromatase
2001
Interaction of the Estrogen Receptors with the Fas Ligand Promoter in Human Monocytes
2003
In vivo Efficacy of STX213, A Second-Generation Steroid Sulfatase Inhibitor, for Hormone-Dependent Breast Cancer Therapy
2006
Sudestada1, a Drosophila ribosomal prolyl-hydroxylase required for mRNA translation, cell homeostasis, and organ growth
2014 StandoutNobel
Sporadic Epithelial Ovarian Cancer: Clinical Relevance of BRCA1 Inhibition in the DNA Damage and Repair Pathway
2008
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance
2008
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Cytosolic Phospholipase A2 Activation Correlates with HER2 Overexpression and Mediates Estrogen-Dependent Breast Cancer Cell Growth
2010
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of Wei Yue being referenced
A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene.
1994
The role of mitogen-activated protein (MAP) kinase in breast cancer
2002
Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity
2005
Farnesylthiosalicylic acid blocks mammalian target of rapamycin signaling in breast cancer cells
2005
Estrogen Mediation of Breast Tumor Formation Involves Estrogen Receptor‐Dependent, as Well as Independent, Genotoxic Effects
2009
Adaptive mechanisms induced by long-term estrogen deprivation in breast cancer cells
2002
Mechanisms of acquired resistance to endocrine therapy in hormone-dependent breast cancer cells
2007
Chapter 5: Tissue-Specific Synthesis and Oxidative Metabolism of Estrogens
2000
MCF-7 human breast carcinomas in nude mice as a model for evaluating aromatase inhibitors
1993
Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells
2009
Determinants of tissue estradiol levels and biologic responsiveness in breast tumors
1998
The effects of aromatase inhibitors and antiestrogens in the nude mouse model
1998
Macrophages, estrogen and the microenvironment of breast cancer
1998
The potential of aromatase inhibitors in breast cancer prevention.
1999
Mechanisms of the actions of aromatase inhibitors 4-hydroxyandrostenedione, fadrozole, and aminoglutethimide on aromatase in JEG-3 cell culture
1997
Adaptive hypersensitivity to estrogen: Mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment
2005
Adaptive hypersensitivity following long-term estrogen deprivation: involvement of multiple signal pathways
2003
Aromatase within the breast.
1999
Farnesylthiosalicylic Acid Inhibits Mammalian Target of Rapamycin (mTOR) Activity Both in Cells andin Vitroby Promoting Dissociation of the mTOR-Raptor Complex
2004
Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression
2005
Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells
2010
Activation of the MAPK Pathway Enhances Sensitivity of MCF-7 Breast Cancer Cells to the Mitogenic Effect of Estradiol
2002
In situ aromatization enhances breast tumor estradiol levels and cellular proliferation.
1998
Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells
2008
Tamoxifen versus Aromatase Inhibitors for Breast Cancer Prevention
2005
The Aromatase Excess Syndrome Is Associated with Feminization of Both Sexes and Autosomal Dominant Transmission of Aberrant P450 Aromatase Gene Transcription1
1998
Estrogen production via the aromatase enzyme in breast carcinoma: which cell type is responsible?
1997
Long-Term Exposure to Tamoxifen Induces Hypersensitivity to Estradiol
2004